{"version":"1.0","provider_name":"Emerging Issues in Technology and the Law: A View from the Bench and Hot Topics in Patents, Antitrust and the Life Sciences","provider_url":"https:\/\/conferences.law.stanford.edu\/ip-law-and-the-biosciences-conference","author_name":"jcarian","author_url":"https:\/\/conferences.law.stanford.edu\/ip-law-and-the-biosciences-conference\/author\/jcarian\/","title":"Antitrust and Patents - Emerging Issues in Technology and the Law: A View from the Bench and Hot Topics in Patents, Antitrust and the Life Sciences","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"MfWBcS8UZo\"><a href=\"https:\/\/conferences.law.stanford.edu\/ip-law-and-the-biosciences-conference\/sessions\/panel_5\/\">Antitrust and Patents<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/conferences.law.stanford.edu\/ip-law-and-the-biosciences-conference\/sessions\/panel_5\/embed\/#?secret=MfWBcS8UZo\" width=\"600\" height=\"338\" title=\"&#8220;Antitrust and Patents&#8221; &#8212; Emerging Issues in Technology and the Law: A View from the Bench and Hot Topics in Patents, Antitrust and the Life Sciences\" data-secret=\"MfWBcS8UZo\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script type=\"text\/javascript\">\n\/* <![CDATA[ *\/\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/conferences.law.stanford.edu\/ip-law-and-the-biosciences-conference\/wp-includes\/js\/wp-embed.min.js\n\/* ]]> *\/\n<\/script>\n","description":"Materials Written submissions on the public interest of Federal Trade Commissioner Chair Lina M. Khan and Commissioner Rebecca Kelly Slaughter (link) Withdrawn 2019 Policy Statement (link) Draft policy statement on licensing negotiations and remedies for standards-essential patents subject to voluntary F\/RAND commitments (link) Policy Statement on Remedies for Standards-Essential Patents Subject to Voluntary F\/RAND Commitments [&hellip;]"}